Leaflet LEFISYO 5mg / ml oral solution
Indicated for: severe pain; opioid dependence
Route of administration: oral
Substance: levomethadone (analgesic and antipyretic)
ATC: N07BC05 (Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
This medicine may increase the risk of heart rhythm disturbances.
Levomethadone is a medication primarily used for the treatment of opioid dependence and the management of severe pain. It is an analog of methadone, with similar properties but greater potency.
This medication works by binding to opioid receptors in the brain, reducing withdrawal symptoms and pain. It is administered orally or by injection, and the dosage is adjusted based on the individual needs of the patient.
Side effects may include drowsiness, dizziness, nausea, constipation, or respiratory depression. Long-term use can lead to dependence, which is why treatment must be closely monitored by a specialist.
Patients should avoid alcohol consumption and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before using levomethadone.
General data about LEFISYO 5mg / ml
- Substance: levomethadone
- Date of last drug list: 01-12-2023
- Commercial code: W68758001
- Concentration: 5mg / ml
- Pharmaceutical form: oral solution
- Quantity: 1
- Product type: generic
- Prescription restrictions: TAB2 - Medicines that are issued with a special prescription (narcotics) in yellow color.